Clinical trial
Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24…
NCT00419705 · PhotoThera, Inc, Industry · Completed
Key facts
| NCT number | NCT00419705 |
|---|---|
| Title | Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) |
| Official title | NeuroThera® Effectiveness and Safety Trial - 2 (NEST-2) A Double Blind, Randomized, Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Effectiveness of the Treatment of Acute Ischemic Stroke With the NeuroThera® Laser System Within 24 Hours From Stroke Onset |
| Lead sponsor | PhotoThera, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Device |
| Interventions | NeuroThera® Laser System |
| Enrollment | 660 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jan 9, 2007 |
| Last update posted | Jun 9, 2011 |
| Countries | Germany, Peru, Sweden, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: